Neclife Lifesciences receives Korean FDA for 'Cefuroxime Axetil'

Pharmaceutical firm NecLife Lifesciences today announced that it has received Korean food and drug administration's (K-FDA) approval for Cefuroxime Axetil (Amorphous).

Portfolio Company News